🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is an evaluation of the diagnostic performance of different tests...
Status
Completed
Location
UH Montpellier
Start Date
2017-01-31
Trial ID
NCT06408129
The primary purpose of this study is to determine the intra and extra pulmo...
Status
Completed
Location
Multiple Locations
Start Date
2004-06-02
Trial ID
NCT05999942
Treatments Being Tested
Thyroid scintigraphy using technetium-99m (99mTc) pertechnetate is traditio...
Status
Completed
Location
Centre Hospitalier Princesse Grace
Start Date
2025-10-01
Trial ID
NCT07610460
Treatments Being Tested
We aim to determine if Molecular Breast Imaging (a new nuclear medicine tec...
Status
Completed
Location
Mayo Clinic
Start Date
2003-08
Trial ID
NCT00620087
Treatments Being Tested
RATIONALE: Monoclonal antibodies such as rituximab and yttrium Y 90 ibritum...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2003-02-10
Trial ID
NCT00058422
This phase III trial compares hepatic arterial infusion (HAI) (pump chemoth...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-10-19
Trial ID
NCT05863195
Renal scintigraphy is an imaging method that uses small amount of radioacti...
Status
Unknown
Location
Sohag University Hospital
Start Date
2022-05
Trial ID
NCT05344807
Treatments Being Tested
This phase II trial tests how well retifanlimab with bevacizumab and hypofr...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2024-10-02
Trial ID
NCT06160206
This study compares molecular breast imaging (MBI) and digital breast tomos...
Status
Completed
Location
Henry Ford Hospital
Start Date
2017-06-14
Trial ID
NCT03220893
Treatments Being Tested
This phase III trial compares the effect of olaparib for one year versus tw...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2025-03-12
Trial ID
NCT06580314
Treatments Being Tested